UBA2
MOLECULAR TARGETubiquitin like modifier activating enzyme 2
UBA2 (ubiquitin like modifier activating enzyme 2) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting UBA2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | DEAD-box RNA Helicases | 1.10 | 2 |
| 2 | Thioctic Acid | 1.10 | 2 |
| 3 | Thioctic Acid | 1.10 | 2 |
| 4 | Rosmarinic Acid | 0.69 | 1 |
| 5 | Demeclocycline | 0.69 | 1 |
| 6 | Edaravone | 0.69 | 1 |
| 7 | Hexachlorophene | 0.69 | 1 |
| 8 | Methyldopa | 0.69 | 1 |
| 9 | rafoxanide | 0.69 | 1 |
About UBA2 as a Drug Target
UBA2 (ubiquitin like modifier activating enzyme 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented UBA2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
UBA2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.